Reckitt Benckiser Group plc (the "Company" or "RB") announces the following change in the interests of a Director in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
On 27 March 2019, Adrian Hennah, Chief Financial Officer, exercised 403 share options granted under the Reckitt Benckiser Group 2007 Savings Related Share Option Plan (the "Sharesave Plan") following the maturity of his 5-year savings contract. The options were granted on 4 September 2013 at an exercise price of £37.20 per share. The Sharesave Plan is an all-employee HMRC approved share scheme and the exercise of options on maturity is not dependent upon performance criteria.
Following this transaction, the total beneficial holding of Shares by Mr Hennah and his connected persons has increased to 104,593 Shares, representing 0.0148 % of the Company's issued share capital. Treasury shares have not been taken into account when calculating this percentage.
The following notification is made in accordance with the requirements of the EU Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Details of the person discharging managerial responsibilities / person closely associated
Reason for the notification
Executive Director - Chief Financial Officer
Initial notification/ Amendment
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Reckitt Benckiser Group plc
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Ordinary shares of 10p each in Reckitt Benckiser Group plc
Nature of the transaction
Exercise of share options granted on 4 September 2013 under the Reckitt Benckiser Group 2007 Savings Related Share Option Plan following the maturity of a 5-year savings contract.
Price(s) and volume(s)
- Aggregated volume
Date of the transaction
Place of the transaction
Outside a trading venue
For further Information: Christine Logan
Deputy Company Secretary Tel +44 (0) 1753 217 800
SVP, Investor Relations
Tel. +44 (0)1753 217 800
Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108
RB* is the global leading consumer health, hygiene and home company. Driven by a purpose of providing innovative solutions for healthier lives and happier homes, RB has operations in over 60 countries. From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, its global brands help people live healthier, happier lives.
RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.
RB's unique culture is at the heart of its success. Its drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 employees worldwide.
*RB is the trading name of the Reckitt Benckiser group of companies
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...